AU638496B2 - Acyl-biphenylyl-alkyl pyrimidine derivatives - Google Patents

Acyl-biphenylyl-alkyl pyrimidine derivatives

Info

Publication number
AU638496B2
AU638496B2 AU64680/90A AU6468090A AU638496B2 AU 638496 B2 AU638496 B2 AU 638496B2 AU 64680/90 A AU64680/90 A AU 64680/90A AU 6468090 A AU6468090 A AU 6468090A AU 638496 B2 AU638496 B2 AU 638496B2
Authority
AU
Australia
Prior art keywords
biphenylyl
acyl
pyrimidine derivatives
alkyl pyrimidine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU64680/90A
Other versions
AU6468090A (en
Inventor
Peter Buhlmayer
Peter Herold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU6468090A publication Critical patent/AU6468090A/en
Application granted granted Critical
Publication of AU638496B2 publication Critical patent/AU638496B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
AU64680/90A 1989-10-19 1990-10-16 Acyl-biphenylyl-alkyl pyrimidine derivatives Ceased AU638496B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH379989 1989-10-19
CH3799/89 1989-10-19

Publications (2)

Publication Number Publication Date
AU6468090A AU6468090A (en) 1991-04-26
AU638496B2 true AU638496B2 (en) 1993-07-01

Family

ID=4263704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64680/90A Ceased AU638496B2 (en) 1989-10-19 1990-10-16 Acyl-biphenylyl-alkyl pyrimidine derivatives

Country Status (14)

Country Link
EP (1) EP0424317A3 (en)
JP (1) JPH03133964A (en)
KR (1) KR910007889A (en)
AU (1) AU638496B2 (en)
CA (1) CA2027839A1 (en)
FI (1) FI93957C (en)
HU (1) HUT55383A (en)
IE (1) IE903749A1 (en)
IL (1) IL96009A0 (en)
MX (1) MX22877A (en)
NO (1) NO176758C (en)
NZ (1) NZ235726A (en)
PT (1) PT95626A (en)
ZA (1) ZA908344B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668357B2 (en) * 1991-08-02 1996-05-02 Istituto Luso Farmaco D. Italia S.P.A. Compounds having angiotensine II antagonistic activity

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015209A1 (en) * 1990-03-30 1991-10-17 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5324729A (en) * 1990-03-30 1994-06-28 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
CA2051705A1 (en) * 1990-06-19 1991-12-20 Kiyoaki Katano Pyridine derivatives having angiotensin ii antagonism
IL99246A0 (en) * 1990-09-10 1992-07-15 Abbott Lab Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
US5250548A (en) * 1990-09-10 1993-10-05 Abbott Laboratories Angiotensin II receptor antagonists
US5472967A (en) * 1991-02-20 1995-12-05 Synthelabo 4-pyrimidinone derivatives their preparation and their application in therapy
FR2672892B1 (en) * 1991-02-20 1994-01-14 Synthelabo DERIVATIVES OF 4-PYRIMIDINONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
DE4110019C2 (en) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridines, processes for their production and pharmaceutical preparations containing them
IL101860A0 (en) * 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
US5256781A (en) * 1991-10-24 1993-10-26 American Home Products Corporation Substituted quinazolines as angiotensin II antagonists
US5236925A (en) * 1991-10-24 1993-08-17 American Home Products Corporation Fused pyrimidines as angiotensin II antagonists
US5234936A (en) * 1991-10-24 1993-08-10 American Home Products Corporation Pyrimidocycloalkanes as a ii antagonists
DE4221583A1 (en) 1991-11-12 1993-05-13 Bayer Ag SUBSTITUTED BIPHENYLPYRIDONE
GB9125842D0 (en) * 1991-12-04 1992-02-05 Ici Plc Heterocyclic derivatives
US5225408A (en) * 1991-12-20 1993-07-06 E. R. Squibb & Sons, Inc. Biphenyl oxadiazinone angiotensin II inhibitors
IL104756A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Composition for the treatment of glaucoma
US5378704A (en) * 1992-04-15 1995-01-03 E. R. Squibb & Sons, Inc. Non-peptidic angiotensin-II-receptor-antagonists
US5236916A (en) * 1992-05-26 1993-08-17 E. R. Squibb & Sons, Inc. Oxadiazinone substituted indole and benzimidazole derivatives
TW348175B (en) * 1993-01-06 1998-12-21 Hoechst Ag Process for the preparation of biphenyl derivatives
US6518424B1 (en) 1998-11-12 2003-02-11 Elan Pharmaceuticals, Inc. Substituted pyrimidine compositions and methods of use
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
US7691898B2 (en) 2004-10-08 2010-04-06 Kotobuki Pharmaceutical Co., Ltd. Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
JP5202301B2 (en) * 2005-04-12 2013-06-05 ヴィコール・ファルマ・アーベー Novel tricyclic angiotensin II agonist
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2011105099A1 (en) * 2010-02-25 2011-09-01 興和株式会社 Compound containing a novel 4-alkoxypyridine formation and medicine containing same
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
WO2022057858A1 (en) * 2020-09-17 2022-03-24 浙江海正药业股份有限公司 Amide phosphine oxide derivative, preparation method therefor, and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668357B2 (en) * 1991-08-02 1996-05-02 Istituto Luso Farmaco D. Italia S.P.A. Compounds having angiotensine II antagonistic activity

Also Published As

Publication number Publication date
NO904511D0 (en) 1990-10-18
FI905124A0 (en) 1990-10-17
IL96009A0 (en) 1991-07-18
HU906501D0 (en) 1991-04-29
EP0424317A3 (en) 1991-09-25
HUT55383A (en) 1991-05-28
KR910007889A (en) 1991-05-30
MX22877A (en) 1993-12-01
ZA908344B (en) 1991-06-26
JPH03133964A (en) 1991-06-07
IE903749A1 (en) 1991-04-24
NO904511L (en) 1991-04-22
NZ235726A (en) 1993-09-27
FI93957C (en) 1995-06-26
FI93957B (en) 1995-03-15
NO176758C (en) 1995-05-24
NO176758B (en) 1995-02-13
EP0424317A2 (en) 1991-04-24
AU6468090A (en) 1991-04-26
CA2027839A1 (en) 1991-04-20
PT95626A (en) 1991-09-13

Similar Documents

Publication Publication Date Title
AU638496B2 (en) Acyl-biphenylyl-alkyl pyrimidine derivatives
EP0407342A3 (en) Pyrimidine derivatives
AU4764990A (en) 3-Aryl-4-hydroxy-delta3-pyrroline-2-one derivatives
AU636155B2 (en) Thienodiazepine derivatives
AU3635789A (en) Fused pyrimidine derivatives
AU6799990A (en) 2-iminopyridine derivatives
AU7684187A (en) Pyrimidine derivatives
AU1018092A (en) Dideoxydidehydrocarbocyclic pyrimidines
AU3388893A (en) Pyrimidine derivatives
AU631896B2 (en) 3-arylurail derivatives
AU8033891A (en) Pyrimidine derivatives
AU2030988A (en) Pyrimidine derivatives
AU6670090A (en) Substituted pyrimidobenzimidazole derivatives
AU582049B2 (en) Pyrimidine derivatives
AU7364287A (en) Pyrimidine derivatives
AU6245690A (en) Guanidine derivatives
AU6204690A (en) Epiopodophyllotoxin altroside derivatives
AU599403B2 (en) Pyrimidine derivatives
AU1631788A (en) Pyrimidine derivatives
AU3020289A (en) Substituted pyrimidines
AU7668587A (en) Pyrimidine derivatives
AU5901690A (en) Hexahydropyrimidine derivatives
AU3526989A (en) 2-amino-pyrimidine derivatives
AU8219287A (en) Pyrimidine derivatives
AU3607189A (en) Pyrimidine derivatives